Clincosm LogoSign in Get a demo

nash

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PCOS, NAFLD, NASH Trial in San Francisco, Durham

Recruiting
  • PCOS
  • +2 more
    • San Francisco, California
    • +1 more
    Nov 3, 2023

    Psoriasis and Non Alcoholic Steatohepatitis: Is ThereShared

    Not yet recruiting
    • Nash
      • (no location specified)
      Aug 15, 2023

      Early Liver Disease Breath Detection

      Not yet recruiting
      • Liver Fibrosis
      • +2 more
      • EVOCs emulsion
      • Norwich, Norfolk, United Kingdom
        One Norwich Practises
      Jun 28, 2023

      NASH Trial in Nottingham (Aramchol)

      Completed
      • NASH
      • Nottingham, United Kingdom
        Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nott
      May 23, 2023

      RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

      Not yet recruiting
      • Overweight and Obesity
      • +6 more
      • Nutritional Psycho-Behavioral Reeducation Program
      • (no location specified)
      May 4, 2023

      NASH Trial in Karachi (Misoprostol, Placebo)

      Completed
      • NASH
      • Karachi, Sindh, Pakistan
        Dr. Ziauddin Hospital Clifton
      Mar 26, 2023

      NASH, NAFLD Trial in Hangzhou (GH509, Placebo)

      Recruiting
      • NASH
      • NAFLD
      • Hangzhou, Zhejiang, China
        The Affiliated Hospital of Hangzhou Normal University
      Mar 26, 2023

      COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver

      Not yet recruiting
      • Chronic or Recovered Hepatitis B
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

        Active, not recruiting
        • Non-alcoholic Fatty Liver Disease
        • +5 more
        • AZD7503 Intervention
        • San Antonio, Texas
          Research Site
        Jan 13, 2023

        Diabetes, Type 2, NAFLD, NASH Trial in Angers, Nantes (Blood tests)

        Recruiting
        • Diabetes Mellitus, Type 2
        • +2 more
        • Blood tests
        • Angers, France
        • +1 more
        Jan 9, 2023

        NASH, NAFLD, NASH With Fibrosis Trial

        Not yet recruiting
        • NASH
        • +8 more
          • (no location specified)
          Dec 13, 2022

          NASH Trial in United States (K-877-ER, CSG452, Placebo)

          Recruiting
          • NASH
          • Homewood, Alabama
          • +31 more
          Dec 1, 2022

          NASH Trial in China (HuHuangLianzonggan capsule, HuHuangLianzonggan capsule )

          Not yet recruiting
          • NASH
          • HuHuangLianzonggan capsule
          • HuHuangLianzonggan capsule placebo
          • Hefei, Anhui, China
          • +19 more
          Nov 20, 2022

          NASH Trial in Puerto Rico, United States (BIO89-100, Placebo)

          Completed
          • NASH
          • Madison, Alabama
          • +25 more
          Nov 28, 2022

          The Visceral Adiposity Measurement and Observation Study

          Recruiting
          • HIV
          • +18 more
          • Diagnostic Test
          • HIV Anti-retroviral Background Therapy
          • Los Angeles, California
          • +5 more
          Sep 21, 2022

          Nonalcoholic Steatohepatitis, NASH Trial in Worldwide (ALN-HSD, Placebo)

          Active, not recruiting
          • Nonalcoholic Steatohepatitis
          • NASH
          • Huntington Park, California
          • +20 more
          Aug 11, 2022

          NASH, Cirrhosis, Liver Trial in North Little Rock (Resmetirom)

          Not yet recruiting
          • NASH
          • Cirrhosis, Liver
          • North Little Rock, Arkansas
            Arkansas Gastroenterology
          Aug 11, 2022

          LITMUS Imaging Study

          Recruiting
          • NAFLD
          • +4 more
            • San Antonio, Texas
            • +17 more
            Jul 26, 2022

            Assessment of Fatty Liver With Thermo-acoustic Device

            Not yet recruiting
            • NASH
            • +6 more
            • Thermo-acuostic image acquisition of liver
            • MRI-PDFF estimation of hepatic fat
            • Milwaukee, Wisconsin
              Froedtert Hospital
            May 23, 2022

            NASH Trial in China (chiglitazar sodium tablets, Placebo)

            Recruiting
            • NASH
            • chiglitazar sodium tablets
            • Placebo
            • Beijing, Beijing, China
            • +14 more
            Mar 22, 2022

            NAFLD, NASH Trial in United States (Elobixibat, Placebo oral tablet)

            Completed
            Has Results
            • NAFLD
            • NASH
            • Canoga Park, California
            • +9 more
            Aug 31, 2021

            NASH, Fatty Liver, NAFLD Trial in Chandler (Noom Healthy Weight Program)

            Enrolling by invitation
            • NASH
            • +3 more
            • Noom Healthy Weight Program
            • Chandler, Arizona
              Arizona Liver Health
            Aug 20, 2021

            NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis Trial (Biological specimens, Additional visit)

            Not yet recruiting
            • NAFLD
            • +4 more
            • Biological specimens
            • Additional visit
            • (no location specified)
            Jun 7, 2021

            NASH, NASH - Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial in Fort Myers, San Antonio (MET409 Active, MET409 Placebo,

            Active, not recruiting
            • NASH
            • +7 more
            • MET409 Active
            • +2 more
            • Fort Myers, Florida
            • +1 more
            May 28, 2021

            Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NAFLD Trial in Maastricht (Plant stanols (3g/day), Placebo)

            Not yet recruiting
            • Non-Alcoholic Fatty Liver Disease
            • +7 more
            • Plant stanols (3g/day)
            • Placebo
            • Maastricht, Netherlands
              Maastricht University Medical Center
            Mar 2, 2021